ES267532A1 - Un procedimiento para hacer un preparado farmaceutico - Google Patents
Un procedimiento para hacer un preparado farmaceuticoInfo
- Publication number
- ES267532A1 ES267532A1 ES0267532A ES267532A ES267532A1 ES 267532 A1 ES267532 A1 ES 267532A1 ES 0267532 A ES0267532 A ES 0267532A ES 267532 A ES267532 A ES 267532A ES 267532 A1 ES267532 A1 ES 267532A1
- Authority
- ES
- Spain
- Prior art keywords
- tablet
- drug
- polymer
- solid
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 title abstract 5
- 230000003111 delayed effect Effects 0.000 title abstract 2
- 239000003826 tablet Substances 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 4
- 229920000642 polymer Polymers 0.000 abstract 3
- 239000007787 solid Substances 0.000 abstract 3
- -1 antispasmodics Substances 0.000 abstract 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 abstract 1
- VCCNKWWXYVWTLT-CYZBKYQRSA-N 7-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)chromen-4-one Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 VCCNKWWXYVWTLT-CYZBKYQRSA-N 0.000 abstract 1
- 239000004721 Polyphenylene oxide Substances 0.000 abstract 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 abstract 1
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 abstract 1
- 229960003556 aminophylline Drugs 0.000 abstract 1
- 239000002269 analeptic agent Substances 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000001139 anti-pruritic effect Effects 0.000 abstract 1
- 230000002921 anti-spasmodic effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229940125681 anticonvulsant agent Drugs 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 229940125715 antihistaminic agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000002579 antinauseant Substances 0.000 abstract 1
- 239000003908 antipruritic agent Substances 0.000 abstract 1
- 229940124575 antispasmodic agent Drugs 0.000 abstract 1
- 230000002716 ataractic effect Effects 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 239000003218 coronary vasodilator agent Substances 0.000 abstract 1
- 229960001903 ergotamine tartrate Drugs 0.000 abstract 1
- 239000005555 hypertensive agent Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229960002342 mephentermine Drugs 0.000 abstract 1
- RXQCGGRTAILOIN-UHFFFAOYSA-N mephentermine Chemical compound CNC(C)(C)CC1=CC=CC=C1 RXQCGGRTAILOIN-UHFFFAOYSA-N 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 229940035363 muscle relaxants Drugs 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 230000001734 parasympathetic effect Effects 0.000 abstract 1
- 239000000810 peripheral vasodilating agent Substances 0.000 abstract 1
- 229960002116 peripheral vasodilator Drugs 0.000 abstract 1
- 150000002990 phenothiazines Chemical class 0.000 abstract 1
- HCTVWSOKIJULET-LQDWTQKMSA-M phenoxymethylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 HCTVWSOKIJULET-LQDWTQKMSA-M 0.000 abstract 1
- 229920000570 polyether Polymers 0.000 abstract 1
- JIVSXRLRGOICGA-UHFFFAOYSA-N promazine hydrochloride Chemical compound [H+].[Cl-].C1=CC=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 JIVSXRLRGOICGA-UHFFFAOYSA-N 0.000 abstract 1
- 229960001836 promazine hydrochloride Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000009491 slugging Methods 0.000 abstract 1
- 229960004025 sodium salicylate Drugs 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000007939 sustained release tablet Substances 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/42—Separation; Purification; Stabilisation; Use of additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
- C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33896A US3074852A (en) | 1960-06-06 | 1960-06-06 | Pharmaceuticals with delayed release |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES267532A1 true ES267532A1 (es) | 1961-11-16 |
Family
ID=21873090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES0267532A Expired ES267532A1 (es) | 1960-06-06 | 1961-05-20 | Un procedimiento para hacer un preparado farmaceutico |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3074852A (enEXAMPLES) |
| BE (1) | BE604564A (enEXAMPLES) |
| DE (1) | DE1279896C2 (enEXAMPLES) |
| ES (1) | ES267532A1 (enEXAMPLES) |
| FI (1) | FI40562B (enEXAMPLES) |
| FR (1) | FR1409M (enEXAMPLES) |
| GB (1) | GB905000A (enEXAMPLES) |
| NL (2) | NL265428A (enEXAMPLES) |
| SE (1) | SE328372B (enEXAMPLES) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL297357A (enEXAMPLES) * | 1962-08-31 | |||
| US3330729A (en) * | 1963-10-04 | 1967-07-11 | Goodrich Co B F | Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent |
| CH415963A (de) * | 1964-09-04 | 1966-06-30 | Wander Ag Dr A | Masse zur Herstellung von Tabletten mit protrahierter Wirkung |
| US3499960A (en) * | 1965-01-25 | 1970-03-10 | Merck & Co Inc | Palatable coated particles of an anion exchange resin |
| GB1137214A (en) * | 1966-06-21 | 1968-12-18 | Commw Scient Ind Res Org | Method and food composition for feeding ruminants |
| US3458622A (en) * | 1967-04-07 | 1969-07-29 | Squibb & Sons Inc | Controlled release tablet |
| IE32806B1 (en) * | 1968-05-21 | 1973-12-12 | American Home Prod | Sustained release drug composition |
| US4309404A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| US4248857A (en) * | 1979-08-09 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| IN151913B (enEXAMPLES) * | 1980-01-11 | 1983-09-03 | Boots Co Ltd | |
| US4308251A (en) * | 1980-01-11 | 1981-12-29 | Boots Pharmaceuticals, Inc. | Controlled release formulations of orally-active medicaments |
| CH666406A5 (de) * | 1984-02-29 | 1988-07-29 | Sandoz Ag | Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten. |
| US4666705A (en) * | 1985-06-03 | 1987-05-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
| US4794001A (en) * | 1986-03-04 | 1988-12-27 | American Home Products Corporation | Formulations providing three distinct releases |
| US4904476A (en) * | 1986-03-04 | 1990-02-27 | American Home Products Corporation | Formulations providing three distinct releases |
| US4994276A (en) * | 1988-09-19 | 1991-02-19 | Edward Mendell Co., Inc. | Directly compressible sustained release excipient |
| CH672922A5 (enEXAMPLES) * | 1987-09-25 | 1990-01-15 | Battelle Memorial Institute | |
| US5169639A (en) * | 1988-09-19 | 1992-12-08 | Edward Mendell Co., Inc. | Controlled release verapamil tablets |
| US5128143A (en) * | 1988-09-19 | 1992-07-07 | Edward Mendell Co., Inc. | Sustained release excipient and tablet formulation |
| US5135757A (en) * | 1988-09-19 | 1992-08-04 | Edward Mendell Co., Inc. | Compressible sustained release solid dosage forms |
| EP0375649A3 (en) * | 1988-12-22 | 1992-05-27 | Monsanto Company | Swelling-controlled oral delivery system for drugs |
| ES2050096T3 (es) | 1989-10-31 | 1995-01-16 | Columbia Lab Inc | Composicion humidificante del tejido vaginal. |
| US5498410A (en) * | 1991-04-22 | 1996-03-12 | Gleich; Gerald J. | Method for the treatment of eosinophil-associated conditions with anionic polymers |
| US5681555A (en) * | 1991-04-22 | 1997-10-28 | Gleich; Gerald J. | Method for the treatment of bronchial asthma by parenteral administration of anionic polymers |
| US5250293A (en) * | 1991-04-22 | 1993-10-05 | Gleich Gerald J | Method for the treatment of hypersensitivity diseases by administration of anionic polymers |
| US5407686A (en) * | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5472711A (en) * | 1992-07-30 | 1995-12-05 | Edward Mendell Co., Inc. | Agglomerated hydrophilic complexes with multi-phasic release characteristics |
| US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
| US5667492A (en) * | 1994-10-07 | 1997-09-16 | Columbia Laboratories, Inc. | Use and composition of an anti-sexually transmitted diseases formulation |
| US6245351B1 (en) * | 1996-03-07 | 2001-06-12 | Takeda Chemical Industries, Ltd. | Controlled-release composition |
| US6596777B1 (en) | 1997-05-29 | 2003-07-22 | Mcneil-Ppc, Inc. | Moisture containing compositions that are spreadable onto and adherable to biomembranes |
| US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| US20010006644A1 (en) * | 1997-07-31 | 2001-07-05 | David J. Bova | Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night |
| IN186245B (enEXAMPLES) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
| JP2004513975A (ja) | 2000-12-05 | 2004-05-13 | マクグレゴール アレキサンダー | 作用物質の制御放出のための静水圧デリバリシステム |
| PA8578501A1 (es) * | 2002-07-25 | 2005-02-04 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
| US20060233878A1 (en) * | 2003-09-30 | 2006-10-19 | Lupin Limited | Extended release formulation of beta-lactam antibiotics |
| CN101884626A (zh) * | 2004-08-13 | 2010-11-17 | 贝林格尔.英格海姆国际有限公司 | 包含普拉克索或其可药用盐的延长释放片剂、其制备方法及用途 |
| KR20070050081A (ko) * | 2004-08-13 | 2007-05-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 프라미펙솔 또는 약제학적으로 허용되는 이의 염을포함하는 연장 방출형 펠렛 제형, 이의 제조방법 및 이의용도 |
| CN101229378A (zh) * | 2005-05-05 | 2008-07-30 | 国家淀粉及化学投资控股公司 | 用于送递活性剂的组合物 |
| US20090098202A1 (en) * | 2006-02-10 | 2009-04-16 | Boehringer Ingelheim International Gmbh | Extended Release Formulation |
| WO2007090881A2 (en) * | 2006-02-10 | 2007-08-16 | Boehringer Ingelheim International Gmbh | Modified release formulation |
| US7538652B2 (en) * | 2006-08-29 | 2009-05-26 | International Business Machines Corporation | Electrical component tuned by conductive layer deletion |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE631201C (de) * | 1932-08-07 | 1936-06-16 | Chemische Forschungs Gmbh | Traegerstoff fuer Arzneimittel |
| DE644759C (de) * | 1932-11-23 | 1937-05-12 | I G Farbenindustrie Akt Ges | Verfahren zum UEberziehen von Arzneiformen mit gegen Magensaeure und Magenfermente bestaendigen UEberzuegen |
| CH283585A (de) * | 1950-03-15 | 1952-06-15 | Hoffmann La Roche | Zur Herstellung von Tablettenüberzügen geeignetes Gemisch. |
| US2798053A (en) * | 1952-09-03 | 1957-07-02 | Goodrich Co B F | Carboxylic polymers |
| BE575343A (enEXAMPLES) * | 1955-09-09 | |||
| US2912358A (en) * | 1955-11-02 | 1959-11-10 | Bristol Myers Co | Antacid preparations containing acrylic acid polymers and magnesium antacids |
| US2909462A (en) * | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| US2854381A (en) * | 1955-12-08 | 1958-09-30 | Bristol Myers Co | Resin laxative tablets containing hydrolyzed keratin |
| US2887436A (en) * | 1956-05-28 | 1959-05-19 | Pfizer & Co C | Pharmaceutical compositions |
| US2887437A (en) * | 1956-08-22 | 1959-05-19 | Pfizer & Co C | Palatable vitamin tablet containing an amino acid |
| US2887439A (en) * | 1956-09-28 | 1959-05-19 | Pfizer & Co C | Palatable antihistamine tablet |
| DE1070381B (de) * | 1957-03-15 | 1959-12-03 | Rohm & LIaas Company, Philadelphia, Pa. (V. St. A.) | Verfahren zur Herstellung von Ionenaustauscherharzen auf Basis der Acrylsäuren und Methacrylsäuren |
| NL230864A (enEXAMPLES) * | 1957-08-27 | |||
| US2918411A (en) * | 1957-11-01 | 1959-12-22 | Olin Mathieson | Pharmaceutical preparations |
| NL109170C (enEXAMPLES) * | 1958-02-03 | |||
| US2957804A (en) * | 1958-06-06 | 1960-10-25 | Harlan R Shuyler | Pesticide |
| US2987445A (en) * | 1958-10-10 | 1961-06-06 | Rohm & Haas | Drug composition |
| US3033754A (en) * | 1959-12-21 | 1962-05-08 | Lakeside Lab Inc | Tablets containing hydrazine derivatives |
-
0
- NL NL128902D patent/NL128902C/xx active
- BE BE604564D patent/BE604564A/xx unknown
- NL NL265428D patent/NL265428A/xx unknown
-
1960
- 1960-06-06 US US33896A patent/US3074852A/en not_active Expired - Lifetime
-
1961
- 1961-05-20 ES ES0267532A patent/ES267532A1/es not_active Expired
- 1961-05-23 GB GB18505/61A patent/GB905000A/en not_active Expired
- 1961-05-24 DE DE1961A0037521 patent/DE1279896C2/de not_active Expired
- 1961-05-29 FI FI1033/61A patent/FI40562B/fi active
- 1961-05-31 SE SE05710/61A patent/SE328372B/xx unknown
- 1961-06-06 FR FR864028A patent/FR1409M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BE604564A (enEXAMPLES) | |
| SE328372B (enEXAMPLES) | 1970-09-14 |
| FR1409M (fr) | 1962-07-23 |
| DE1279896B (de) | 1968-10-10 |
| FI40562B (enEXAMPLES) | 1968-11-30 |
| NL128902C (enEXAMPLES) | |
| GB905000A (en) | 1962-09-05 |
| US3074852A (en) | 1963-01-22 |
| NL265428A (enEXAMPLES) | |
| DE1279896C2 (de) | 1974-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES267532A1 (es) | Un procedimiento para hacer un preparado farmaceutico | |
| EP0247634A3 (en) | Coated dosage forms | |
| CA2168249C (en) | Psoriasis treatment | |
| AU563725B2 (en) | Oral controlled release multiple unit formulation | |
| UA41873C2 (uk) | Композиція аерозолю, що знаходиться під тиском | |
| US10328034B2 (en) | Polymeric adhesive matrix with salified carboxylic groups for transdermal use | |
| NZ514946A (en) | Transdermal therapeutic system comprising neutralized pressure-sensitive acrylate adhesives | |
| ES2032450T3 (es) | Un procedimiento para preparar acetaminofen secado por pulverizacion. | |
| GR1000254B (el) | Μεθοδος παρασκευης διαμορφωσεως ακεταμινοφαινης βραδειας απελευθερωσεως απο το στομα. | |
| KR910011242A (ko) | 서방성 약학제제 및 그의 제조방법 | |
| CA2391832A1 (en) | Oral dosage forms | |
| ES8802115A1 (es) | Procedimiento para la preparacion de formas de administracion de medicamentos solidas y duraderas a base de hidroxipropilcelulosa. | |
| ATE230426T1 (de) | Überzugs- und bindemittel für orale oder dermale arzneiformen | |
| UA5328A1 (uk) | Спосіб одержання таблеток | |
| GB1324197A (en) | Coated pharmaceutical preparations | |
| MX9701465A (es) | Formulacion de acetaminofeno, de liberacion sostenida. | |
| EP0284039A3 (en) | Slow-release pharmaceutical composition | |
| RU2000101023A (ru) | Анальгетик с контролируемым высвобождением активного вещества | |
| ES340677A1 (es) | Procedimiento para la preparacion de lacas para revestir grageas. | |
| SE8803822D0 (sv) | Novel dosage form | |
| CA2299423A1 (en) | Taste-masked pharmaceutical composition | |
| WO2002060417A8 (de) | Lagerstabiles haft- und bindemittel für pharmazeutische anwendungen | |
| ES8802396A1 (es) | Procedimiento de obtencion de una composicion de revestimiento para formas de dosificacion de liberacion sostenida | |
| GB1358001A (en) | Pharmaceutical compositions | |
| GB1293529A (en) | Polyampholytes |